AGR2 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "AGR2" in English language version.

refsWebsite

Global rank English rank

54nih.gov

4^th place

33doi.org

2^nd place

9semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

2harvard.edu

18^th place

17^th place

1proteinatlas.org

low place

1hopkinsbreastcenter.org

low place

1web.archive.org

1^st place

1uninsubria.it

low place

1worldcat.org

5^th place

1handle.net

102^nd place

76^th place

doi.org

Aberger F, Weidinger G, Grunz H, Richter K (March 1998). "Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2". Mech. Dev. 72 (1–2): 115–30. doi:10.1016/S0925-4773(98)00021-5. PMID 9533957. S2CID 15262006.
Pohler E, Craig AL, Cotton J, Lawrie L, Dillon JF, Ross P, Kernohan N, Hupp TR (June 2004). "The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage". Mol. Cell. Proteomics. 3 (6): 534–47. doi:10.1074/mcp.M300089-MCP200. PMID 14967811.
Wang Z, Hao Y, Lowe AW (January 2008). "The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation". Cancer Res. 68 (2): 492–7. doi:10.1158/0008-5472.CAN-07-2930. PMID 18199544.
Bu H, Bormann S, Schäfer G, Horninger W, Massoner P, Neeb A, Lakshmanan VK, Maddalo D, Nestl A, Sültmann H, Cato AC, Klocker H (May 2011). "The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection". Prostate. 71 (6): 575–87. doi:10.1002/pros.21273. PMID 20945500. S2CID 1861353.
Sive HL, Hattori K, Weintraub H (July 1989). "Progressive determination during formation of the anteroposterior axis in Xenopus laevis". Cell. 58 (1): 171–80. doi:10.1016/0092-8674(89)90413-3. PMID 2752418. S2CID 40970928.
Sive H, Bradley L (March 1996). "A sticky problem: the Xenopus cement gland as a paradigm for anteroposterior patterning". Dev. Dyn. 205 (3): 265–80. doi:10.1002/(SICI)1097-0177(199603)205:3<265::AID-AJA7>3.0.CO;2-G. PMID 8850563. S2CID 22326745.
Aberger F, Weidinger G, Grunz H, Richter K (March 1998). "Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2". Mech. Dev. 72 (1–2): 115–30. doi:10.1016/S0925-4773(98)00021-5. PMID 9533957. S2CID 15262006.
Thompson DA, Weigel RJ (October 1998). "hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines". Biochem. Biophys. Res. Commun. 251 (1): 111–6. doi:10.1006/bbrc.1998.9440. PMID 9790916.
Vanderlaag KE, Hudak S, Bald L, Fayadat-Dilman L, Sathe M, Grein J, Janatpour MJ (2010). "Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin". Breast Cancer Res. 12 (3): R32. doi:10.1186/bcr2586. PMC 2917027. PMID 20525379.
Galligan JJ, Petersen DR (July 2012). "The human protein disulfide isomerase gene family". Human Genomics. 6 (1): 6. doi:10.1186/1479-7364-6-6. PMC 3500226. PMID 23245351.
Persson S, Rosenquist M, Knoblach B, Khosravi-Far R, Sommarin M, Michalak M (September 2005). "Diversity of the protein disulfide isomerase family: identification of breast tumor induced Hag2 and Hag3 as novel members of the protein family". Mol. Phylogenet. Evol. 36 (3): 734–40. doi:10.1016/j.ympev.2005.04.002. PMID 15935701.
Park SW, Zhen G, Verhaeghe C, Nakagami Y, Nguyenvu LT, Barczak AJ, Killeen N, Erle DJ (April 2009). "The protein disulfide isomerase AGR2 is essential for production of intestinal mucus". Proc. Natl. Acad. Sci. U.S.A. 106 (17): 6950–5. Bibcode:2009PNAS..106.6950P. doi:10.1073/pnas.0808722106. PMC 2678445. PMID 19359471.
Gupta A, Dong A, Lowe AW (2012). "AGR2 gene function requires a unique endoplasmic reticulum localization motif". J. Biol. Chem. 287 (7): 4773–82. doi:10.1074/jbc.M111.301531. PMC 3281655. PMID 22184114.
Petek E, Windpassinger C, Egger H, Kroisel PM, Wagner K (2000). "Localization of the human anterior gradient-2 gene (AGR2) to chromosome band 7p21.3 by radiation hybrid mapping and fluorescencein situ hybridisation". Cytogenet. Cell Genet. 89 (3–4): 141–2. doi:10.1159/000015594. PMID 10965104. S2CID 19307750.
Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB, Lowe AW (September 2006). "Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma". Gastroenterology. 131 (3): 925–33. doi:10.1053/j.gastro.2006.04.026. PMC 2575112. PMID 16952561.
Maley CC, Rustgi AK (April 2006). "Barrett's esophagus and its progression to adenocarcinoma". J Natl Compr Canc Netw. 4 (4): 367–74. doi:10.6004/jnccn.2006.0031. PMID 16569389.
Barraclough DL, Platt-Higgins A, de Silva Rudland S, Barraclough R, Winstanley J, West CR, Rudland PS (November 2009). "The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients". Am. J. Pathol. 175 (5): 1848–57. doi:10.2353/ajpath.2009.090246. PMC 2774050. PMID 19834055.
Maresh EL, Mah V, Alavi M, Horvath S, Bagryanova L, Liebeskind ES, Knutzen LA, Zhou Y, Chia D, Liu AY, Goodglick L (2010). "Differential expression of anterior gradient gene AGR2 in prostate cancer". BMC Cancer. 10: 680. doi:10.1186/1471-2407-10-680. PMC 3009682. PMID 21144054.
Zheng W, Rosenstiel P, Huse K, Sina C, Valentonyte R, Mah N, Zeitlmann L, Grosse J, Ruf N, Nürnberg P, Costello CM, Onnie C, Mathew C, Platzer M, Schreiber S, Hampe J (January 2006). "Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease". Genes Immun. 7 (1): 11–8. doi:10.1038/sj.gene.6364263. PMID 16222343. S2CID 10046565.
Hrstka R, Nenutil R, Fourtouna A, Maslon MM, Naughton C, Langdon S, Murray E, Larionov A, Petrakova K, Muller P, Dixon MJ, Hupp TR, Vojtesek B (August 2010). "The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers". Oncogene. 29 (34): 4838–47. doi:10.1038/onc.2010.228. PMID 20531310. S2CID 21135835.
Innes HE, Liu D, Barraclough R, Davies MP, O'Neill PA, Platt-Higgins A, de Silva Rudland S, Sibson DR, Rudland PS (April 2006). "Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients". Br. J. Cancer. 94 (7): 1057–65. doi:10.1038/sj.bjc.6603065. PMC 2361240. PMID 16598187.
Hengel SM, Murray E, Langdon S, Hayward L, O'Donoghue J, Panchaud A, Hupp T, Goodlett DR (October 2011). "Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance". J. Proteome Res. 10 (10): 4567–78. doi:10.1021/pr2004117. PMC 3242698. PMID 21936522.
Hrstka R, Brychtova V, Fabian P, Vojtesek B, Svoboda M (2013). "AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients". Dis. Markers. 35 (4): 207–12. doi:10.1155/2013/761537. PMC 3776368. PMID 24167368.
Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB, Hortobagyi GN (2012). "Combination anastrozole and fulvestrant in metastatic breast cancer". N. Engl. J. Med. 367 (5): 435–44. doi:10.1056/NEJMoa1201622. PMC 3951300. PMID 22853014.
Whitesell L, Lindquist SL (2005). "HSP90 and the chaperoning of cancer" (PDF). Nat. Rev. Cancer. 5 (10): 761–72. doi:10.1038/nrc1716. PMID 16175177. S2CID 22098282. Archived from the original (PDF) on 2014-03-27. Retrieved 2019-09-27.
Simpson NE, Lambert WM, Watkins R, Giashuddin S, Huang SJ, Oxelmark E, Arju R, Hochman T, Goldberg JD, Schneider RJ, Reiz LF, Soares FA, Logan SK, Garabedian MJ (2010). "High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance". Cancer Res. 70 (21): 8446–56. doi:10.1158/0008-5472.CAN-10-1590. PMC 3007122. PMID 20847343.
Verma S, Salmans ML, Geyfman M, Wang H, Yu Z, Lu Z, Zhao F, Lipkin SM, Andersen B (2012). "The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development". Dev. Biol. 369 (2): 249–60. doi:10.1016/j.ydbio.2012.06.030. PMC 3465459. PMID 22819674.
Chanda D, Lee JH, Sawant A, Hensel JA, Isayeva T, Reilly SD, Siegal GP, Smith C, Grizzle W, Singh R, Ponnazhagan S (2014). "Anterior gradient protein-2 is a regulator of cellular adhesion in prostate cancer". PLOS ONE. 9 (2): e89940. Bibcode:2014PLoSO...989940C. doi:10.1371/journal.pone.0089940. PMC 3937391. PMID 24587138.
Hu Z, Gu Y, Han B, Zhang J, Li Z, Tian K, Young CY, Yuan H (2012). "Knockdown of AGR2 induces cellular senescence in prostate cancer cells". Carcinogenesis. 33 (6): 1178–86. doi:10.1093/carcin/bgs141. PMID 22467239.
Norris, Joseph M.; Simpson, Benjamin S.; Parry, Marina A.; Allen, Clare; Ball, Rhys; Freeman, Alex; Kelly, Daniel; Kim, Hyung L.; Kirkham, Alex; You, Sungyong; Kasivisvanathan, Veeru (2020-07-01). "Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis". European Urology Open Science. 20: 37–47. doi:10.1016/j.euros.2020.06.006. ISSN 2666-1683. PMC 7497895. PMID 33000006.
Ramachandran V, Arumugam T, Wang H, Logsdon CD (October 2008). "Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival". Cancer Res. 68 (19): 7811–8. doi:10.1158/0008-5472.CAN-08-1320. PMC 4429896. PMID 18829536.
Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, Terrett JA (February 2003). "hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan". Br. J. Cancer. 88 (4): 579–85. doi:10.1038/sj.bjc.6600740. PMC 2377166. PMID 12592373.
Maslon MM, Hrstka R, Vojtesek B, Hupp TR (2010). "A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for Reptin". J. Mol. Biol. 404 (3): 418–38. doi:10.1016/j.jmb.2010.09.035. hdl:1842/6477. PMID 20888340.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000106541 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000020581 – Ensembl, May 2017

handle.net

hdl.handle.net

Maslon MM, Hrstka R, Vojtesek B, Hupp TR (2010). "A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for Reptin". J. Mol. Biol. 404 (3): 418–38. doi:10.1016/j.jmb.2010.09.035. hdl:1842/6477. PMID 20888340.

harvard.edu

ui.adsabs.harvard.edu

Park SW, Zhen G, Verhaeghe C, Nakagami Y, Nguyenvu LT, Barczak AJ, Killeen N, Erle DJ (April 2009). "The protein disulfide isomerase AGR2 is essential for production of intestinal mucus". Proc. Natl. Acad. Sci. U.S.A. 106 (17): 6950–5. Bibcode:2009PNAS..106.6950P. doi:10.1073/pnas.0808722106. PMC 2678445. PMID 19359471.
Chanda D, Lee JH, Sawant A, Hensel JA, Isayeva T, Reilly SD, Siegal GP, Smith C, Grizzle W, Singh R, Ponnazhagan S (2014). "Anterior gradient protein-2 is a regulator of cellular adhesion in prostate cancer". PLOS ONE. 9 (2): e89940. Bibcode:2014PLoSO...989940C. doi:10.1371/journal.pone.0089940. PMC 3937391. PMID 24587138.

hopkinsbreastcenter.org

"Scientists Unravel Resistance to Breast Cancer Treatment". Artemis. Retrieved 26 February 2014.

nih.gov

pubmed.ncbi.nlm.nih.gov

Aberger F, Weidinger G, Grunz H, Richter K (March 1998). "Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2". Mech. Dev. 72 (1–2): 115–30. doi:10.1016/S0925-4773(98)00021-5. PMID 9533957. S2CID 15262006.
Pohler E, Craig AL, Cotton J, Lawrie L, Dillon JF, Ross P, Kernohan N, Hupp TR (June 2004). "The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage". Mol. Cell. Proteomics. 3 (6): 534–47. doi:10.1074/mcp.M300089-MCP200. PMID 14967811.
Wang Z, Hao Y, Lowe AW (January 2008). "The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation". Cancer Res. 68 (2): 492–7. doi:10.1158/0008-5472.CAN-07-2930. PMID 18199544.
Bu H, Bormann S, Schäfer G, Horninger W, Massoner P, Neeb A, Lakshmanan VK, Maddalo D, Nestl A, Sültmann H, Cato AC, Klocker H (May 2011). "The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection". Prostate. 71 (6): 575–87. doi:10.1002/pros.21273. PMID 20945500. S2CID 1861353.
Sive HL, Hattori K, Weintraub H (July 1989). "Progressive determination during formation of the anteroposterior axis in Xenopus laevis". Cell. 58 (1): 171–80. doi:10.1016/0092-8674(89)90413-3. PMID 2752418. S2CID 40970928.
Sive H, Bradley L (March 1996). "A sticky problem: the Xenopus cement gland as a paradigm for anteroposterior patterning". Dev. Dyn. 205 (3): 265–80. doi:10.1002/(SICI)1097-0177(199603)205:3<265::AID-AJA7>3.0.CO;2-G. PMID 8850563. S2CID 22326745.
Aberger F, Weidinger G, Grunz H, Richter K (March 1998). "Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2". Mech. Dev. 72 (1–2): 115–30. doi:10.1016/S0925-4773(98)00021-5. PMID 9533957. S2CID 15262006.
Thompson DA, Weigel RJ (October 1998). "hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines". Biochem. Biophys. Res. Commun. 251 (1): 111–6. doi:10.1006/bbrc.1998.9440. PMID 9790916.
Vanderlaag KE, Hudak S, Bald L, Fayadat-Dilman L, Sathe M, Grein J, Janatpour MJ (2010). "Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin". Breast Cancer Res. 12 (3): R32. doi:10.1186/bcr2586. PMC 2917027. PMID 20525379.
Galligan JJ, Petersen DR (July 2012). "The human protein disulfide isomerase gene family". Human Genomics. 6 (1): 6. doi:10.1186/1479-7364-6-6. PMC 3500226. PMID 23245351.
Persson S, Rosenquist M, Knoblach B, Khosravi-Far R, Sommarin M, Michalak M (September 2005). "Diversity of the protein disulfide isomerase family: identification of breast tumor induced Hag2 and Hag3 as novel members of the protein family". Mol. Phylogenet. Evol. 36 (3): 734–40. doi:10.1016/j.ympev.2005.04.002. PMID 15935701.
Park SW, Zhen G, Verhaeghe C, Nakagami Y, Nguyenvu LT, Barczak AJ, Killeen N, Erle DJ (April 2009). "The protein disulfide isomerase AGR2 is essential for production of intestinal mucus". Proc. Natl. Acad. Sci. U.S.A. 106 (17): 6950–5. Bibcode:2009PNAS..106.6950P. doi:10.1073/pnas.0808722106. PMC 2678445. PMID 19359471.
Gupta A, Dong A, Lowe AW (2012). "AGR2 gene function requires a unique endoplasmic reticulum localization motif". J. Biol. Chem. 287 (7): 4773–82. doi:10.1074/jbc.M111.301531. PMC 3281655. PMID 22184114.
Petek E, Windpassinger C, Egger H, Kroisel PM, Wagner K (2000). "Localization of the human anterior gradient-2 gene (AGR2) to chromosome band 7p21.3 by radiation hybrid mapping and fluorescencein situ hybridisation". Cytogenet. Cell Genet. 89 (3–4): 141–2. doi:10.1159/000015594. PMID 10965104. S2CID 19307750.
Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB, Lowe AW (September 2006). "Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma". Gastroenterology. 131 (3): 925–33. doi:10.1053/j.gastro.2006.04.026. PMC 2575112. PMID 16952561.
Maley CC, Rustgi AK (April 2006). "Barrett's esophagus and its progression to adenocarcinoma". J Natl Compr Canc Netw. 4 (4): 367–74. doi:10.6004/jnccn.2006.0031. PMID 16569389.
Barraclough DL, Platt-Higgins A, de Silva Rudland S, Barraclough R, Winstanley J, West CR, Rudland PS (November 2009). "The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients". Am. J. Pathol. 175 (5): 1848–57. doi:10.2353/ajpath.2009.090246. PMC 2774050. PMID 19834055.
Maresh EL, Mah V, Alavi M, Horvath S, Bagryanova L, Liebeskind ES, Knutzen LA, Zhou Y, Chia D, Liu AY, Goodglick L (2010). "Differential expression of anterior gradient gene AGR2 in prostate cancer". BMC Cancer. 10: 680. doi:10.1186/1471-2407-10-680. PMC 3009682. PMID 21144054.
Zheng W, Rosenstiel P, Huse K, Sina C, Valentonyte R, Mah N, Zeitlmann L, Grosse J, Ruf N, Nürnberg P, Costello CM, Onnie C, Mathew C, Platzer M, Schreiber S, Hampe J (January 2006). "Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease". Genes Immun. 7 (1): 11–8. doi:10.1038/sj.gene.6364263. PMID 16222343. S2CID 10046565.
Hrstka R, Nenutil R, Fourtouna A, Maslon MM, Naughton C, Langdon S, Murray E, Larionov A, Petrakova K, Muller P, Dixon MJ, Hupp TR, Vojtesek B (August 2010). "The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers". Oncogene. 29 (34): 4838–47. doi:10.1038/onc.2010.228. PMID 20531310. S2CID 21135835.
Innes HE, Liu D, Barraclough R, Davies MP, O'Neill PA, Platt-Higgins A, de Silva Rudland S, Sibson DR, Rudland PS (April 2006). "Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients". Br. J. Cancer. 94 (7): 1057–65. doi:10.1038/sj.bjc.6603065. PMC 2361240. PMID 16598187.
Hengel SM, Murray E, Langdon S, Hayward L, O'Donoghue J, Panchaud A, Hupp T, Goodlett DR (October 2011). "Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance". J. Proteome Res. 10 (10): 4567–78. doi:10.1021/pr2004117. PMC 3242698. PMID 21936522.
Hrstka R, Brychtova V, Fabian P, Vojtesek B, Svoboda M (2013). "AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients". Dis. Markers. 35 (4): 207–12. doi:10.1155/2013/761537. PMC 3776368. PMID 24167368.
Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB, Hortobagyi GN (2012). "Combination anastrozole and fulvestrant in metastatic breast cancer". N. Engl. J. Med. 367 (5): 435–44. doi:10.1056/NEJMoa1201622. PMC 3951300. PMID 22853014.
Whitesell L, Lindquist SL (2005). "HSP90 and the chaperoning of cancer" (PDF). Nat. Rev. Cancer. 5 (10): 761–72. doi:10.1038/nrc1716. PMID 16175177. S2CID 22098282. Archived from the original (PDF) on 2014-03-27. Retrieved 2019-09-27.
Simpson NE, Lambert WM, Watkins R, Giashuddin S, Huang SJ, Oxelmark E, Arju R, Hochman T, Goldberg JD, Schneider RJ, Reiz LF, Soares FA, Logan SK, Garabedian MJ (2010). "High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance". Cancer Res. 70 (21): 8446–56. doi:10.1158/0008-5472.CAN-10-1590. PMC 3007122. PMID 20847343.
Verma S, Salmans ML, Geyfman M, Wang H, Yu Z, Lu Z, Zhao F, Lipkin SM, Andersen B (2012). "The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development". Dev. Biol. 369 (2): 249–60. doi:10.1016/j.ydbio.2012.06.030. PMC 3465459. PMID 22819674.
Chanda D, Lee JH, Sawant A, Hensel JA, Isayeva T, Reilly SD, Siegal GP, Smith C, Grizzle W, Singh R, Ponnazhagan S (2014). "Anterior gradient protein-2 is a regulator of cellular adhesion in prostate cancer". PLOS ONE. 9 (2): e89940. Bibcode:2014PLoSO...989940C. doi:10.1371/journal.pone.0089940. PMC 3937391. PMID 24587138.
Hu Z, Gu Y, Han B, Zhang J, Li Z, Tian K, Young CY, Yuan H (2012). "Knockdown of AGR2 induces cellular senescence in prostate cancer cells". Carcinogenesis. 33 (6): 1178–86. doi:10.1093/carcin/bgs141. PMID 22467239.
Norris, Joseph M.; Simpson, Benjamin S.; Parry, Marina A.; Allen, Clare; Ball, Rhys; Freeman, Alex; Kelly, Daniel; Kim, Hyung L.; Kirkham, Alex; You, Sungyong; Kasivisvanathan, Veeru (2020-07-01). "Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis". European Urology Open Science. 20: 37–47. doi:10.1016/j.euros.2020.06.006. ISSN 2666-1683. PMC 7497895. PMID 33000006.
Ramachandran V, Arumugam T, Wang H, Logsdon CD (October 2008). "Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival". Cancer Res. 68 (19): 7811–8. doi:10.1158/0008-5472.CAN-08-1320. PMC 4429896. PMID 18829536.
Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH (December 2003). "Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies". Cancer Res. 63 (24): 8614–22. PMID 14695172.
Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, Terrett JA (February 2003). "hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan". Br. J. Cancer. 88 (4): 579–85. doi:10.1038/sj.bjc.6600740. PMC 2377166. PMID 12592373.
Maslon MM, Hrstka R, Vojtesek B, Hupp TR (2010). "A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for Reptin". J. Mol. Biol. 404 (3): 418–38. doi:10.1016/j.jmb.2010.09.035. hdl:1842/6477. PMID 20888340.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: AGR2 anterior gradient homolog 2 (Xenopus laevis)".
Vanderlaag KE, Hudak S, Bald L, Fayadat-Dilman L, Sathe M, Grein J, Janatpour MJ (2010). "Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin". Breast Cancer Res. 12 (3): R32. doi:10.1186/bcr2586. PMC 2917027. PMID 20525379.
Galligan JJ, Petersen DR (July 2012). "The human protein disulfide isomerase gene family". Human Genomics. 6 (1): 6. doi:10.1186/1479-7364-6-6. PMC 3500226. PMID 23245351.
Park SW, Zhen G, Verhaeghe C, Nakagami Y, Nguyenvu LT, Barczak AJ, Killeen N, Erle DJ (April 2009). "The protein disulfide isomerase AGR2 is essential for production of intestinal mucus". Proc. Natl. Acad. Sci. U.S.A. 106 (17): 6950–5. Bibcode:2009PNAS..106.6950P. doi:10.1073/pnas.0808722106. PMC 2678445. PMID 19359471.
Gupta A, Dong A, Lowe AW (2012). "AGR2 gene function requires a unique endoplasmic reticulum localization motif". J. Biol. Chem. 287 (7): 4773–82. doi:10.1074/jbc.M111.301531. PMC 3281655. PMID 22184114.
Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB, Lowe AW (September 2006). "Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma". Gastroenterology. 131 (3): 925–33. doi:10.1053/j.gastro.2006.04.026. PMC 2575112. PMID 16952561.
Barraclough DL, Platt-Higgins A, de Silva Rudland S, Barraclough R, Winstanley J, West CR, Rudland PS (November 2009). "The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients". Am. J. Pathol. 175 (5): 1848–57. doi:10.2353/ajpath.2009.090246. PMC 2774050. PMID 19834055.
Maresh EL, Mah V, Alavi M, Horvath S, Bagryanova L, Liebeskind ES, Knutzen LA, Zhou Y, Chia D, Liu AY, Goodglick L (2010). "Differential expression of anterior gradient gene AGR2 in prostate cancer". BMC Cancer. 10: 680. doi:10.1186/1471-2407-10-680. PMC 3009682. PMID 21144054.
Innes HE, Liu D, Barraclough R, Davies MP, O'Neill PA, Platt-Higgins A, de Silva Rudland S, Sibson DR, Rudland PS (April 2006). "Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients". Br. J. Cancer. 94 (7): 1057–65. doi:10.1038/sj.bjc.6603065. PMC 2361240. PMID 16598187.
Hengel SM, Murray E, Langdon S, Hayward L, O'Donoghue J, Panchaud A, Hupp T, Goodlett DR (October 2011). "Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance". J. Proteome Res. 10 (10): 4567–78. doi:10.1021/pr2004117. PMC 3242698. PMID 21936522.
Hrstka R, Brychtova V, Fabian P, Vojtesek B, Svoboda M (2013). "AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients". Dis. Markers. 35 (4): 207–12. doi:10.1155/2013/761537. PMC 3776368. PMID 24167368.
Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB, Hortobagyi GN (2012). "Combination anastrozole and fulvestrant in metastatic breast cancer". N. Engl. J. Med. 367 (5): 435–44. doi:10.1056/NEJMoa1201622. PMC 3951300. PMID 22853014.
Simpson NE, Lambert WM, Watkins R, Giashuddin S, Huang SJ, Oxelmark E, Arju R, Hochman T, Goldberg JD, Schneider RJ, Reiz LF, Soares FA, Logan SK, Garabedian MJ (2010). "High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance". Cancer Res. 70 (21): 8446–56. doi:10.1158/0008-5472.CAN-10-1590. PMC 3007122. PMID 20847343.
Verma S, Salmans ML, Geyfman M, Wang H, Yu Z, Lu Z, Zhao F, Lipkin SM, Andersen B (2012). "The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development". Dev. Biol. 369 (2): 249–60. doi:10.1016/j.ydbio.2012.06.030. PMC 3465459. PMID 22819674.
Chanda D, Lee JH, Sawant A, Hensel JA, Isayeva T, Reilly SD, Siegal GP, Smith C, Grizzle W, Singh R, Ponnazhagan S (2014). "Anterior gradient protein-2 is a regulator of cellular adhesion in prostate cancer". PLOS ONE. 9 (2): e89940. Bibcode:2014PLoSO...989940C. doi:10.1371/journal.pone.0089940. PMC 3937391. PMID 24587138.
Norris, Joseph M.; Simpson, Benjamin S.; Parry, Marina A.; Allen, Clare; Ball, Rhys; Freeman, Alex; Kelly, Daniel; Kim, Hyung L.; Kirkham, Alex; You, Sungyong; Kasivisvanathan, Veeru (2020-07-01). "Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis". European Urology Open Science. 20: 37–47. doi:10.1016/j.euros.2020.06.006. ISSN 2666-1683. PMC 7497895. PMID 33000006.
Ramachandran V, Arumugam T, Wang H, Logsdon CD (October 2008). "Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival". Cancer Res. 68 (19): 7811–8. doi:10.1158/0008-5472.CAN-08-1320. PMC 4429896. PMID 18829536.
Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, Terrett JA (February 2003). "hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan". Br. J. Cancer. 88 (4): 579–85. doi:10.1038/sj.bjc.6600740. PMC 2377166. PMID 12592373.

proteinatlas.org

"Anterior gradient 2 homolog (Xenopus laevis)". Gene/Protein. The Human Protein Atlas. Retrieved 28 February 2014.

semanticscholar.org

api.semanticscholar.org

Aberger F, Weidinger G, Grunz H, Richter K (March 1998). "Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2". Mech. Dev. 72 (1–2): 115–30. doi:10.1016/S0925-4773(98)00021-5. PMID 9533957. S2CID 15262006.
Bu H, Bormann S, Schäfer G, Horninger W, Massoner P, Neeb A, Lakshmanan VK, Maddalo D, Nestl A, Sültmann H, Cato AC, Klocker H (May 2011). "The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection". Prostate. 71 (6): 575–87. doi:10.1002/pros.21273. PMID 20945500. S2CID 1861353.
Sive HL, Hattori K, Weintraub H (July 1989). "Progressive determination during formation of the anteroposterior axis in Xenopus laevis". Cell. 58 (1): 171–80. doi:10.1016/0092-8674(89)90413-3. PMID 2752418. S2CID 40970928.
Sive H, Bradley L (March 1996). "A sticky problem: the Xenopus cement gland as a paradigm for anteroposterior patterning". Dev. Dyn. 205 (3): 265–80. doi:10.1002/(SICI)1097-0177(199603)205:3<265::AID-AJA7>3.0.CO;2-G. PMID 8850563. S2CID 22326745.
Aberger F, Weidinger G, Grunz H, Richter K (March 1998). "Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2". Mech. Dev. 72 (1–2): 115–30. doi:10.1016/S0925-4773(98)00021-5. PMID 9533957. S2CID 15262006.
Petek E, Windpassinger C, Egger H, Kroisel PM, Wagner K (2000). "Localization of the human anterior gradient-2 gene (AGR2) to chromosome band 7p21.3 by radiation hybrid mapping and fluorescencein situ hybridisation". Cytogenet. Cell Genet. 89 (3–4): 141–2. doi:10.1159/000015594. PMID 10965104. S2CID 19307750.
Zheng W, Rosenstiel P, Huse K, Sina C, Valentonyte R, Mah N, Zeitlmann L, Grosse J, Ruf N, Nürnberg P, Costello CM, Onnie C, Mathew C, Platzer M, Schreiber S, Hampe J (January 2006). "Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease". Genes Immun. 7 (1): 11–8. doi:10.1038/sj.gene.6364263. PMID 16222343. S2CID 10046565.
Hrstka R, Nenutil R, Fourtouna A, Maslon MM, Naughton C, Langdon S, Murray E, Larionov A, Petrakova K, Muller P, Dixon MJ, Hupp TR, Vojtesek B (August 2010). "The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers". Oncogene. 29 (34): 4838–47. doi:10.1038/onc.2010.228. PMID 20531310. S2CID 21135835.
Whitesell L, Lindquist SL (2005). "HSP90 and the chaperoning of cancer" (PDF). Nat. Rev. Cancer. 5 (10): 761–72. doi:10.1038/nrc1716. PMID 16175177. S2CID 22098282. Archived from the original (PDF) on 2014-03-27. Retrieved 2019-09-27.

uninsubria.it

dipbsf.uninsubria.it

Whitesell L, Lindquist SL (2005). "HSP90 and the chaperoning of cancer" (PDF). Nat. Rev. Cancer. 5 (10): 761–72. doi:10.1038/nrc1716. PMID 16175177. S2CID 22098282. Archived from the original (PDF) on 2014-03-27. Retrieved 2019-09-27.

web.archive.org

Whitesell L, Lindquist SL (2005). "HSP90 and the chaperoning of cancer" (PDF). Nat. Rev. Cancer. 5 (10): 761–72. doi:10.1038/nrc1716. PMID 16175177. S2CID 22098282. Archived from the original (PDF) on 2014-03-27. Retrieved 2019-09-27.

worldcat.org

search.worldcat.org

Norris, Joseph M.; Simpson, Benjamin S.; Parry, Marina A.; Allen, Clare; Ball, Rhys; Freeman, Alex; Kelly, Daniel; Kim, Hyung L.; Kirkham, Alex; You, Sungyong; Kasivisvanathan, Veeru (2020-07-01). "Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis". European Urology Open Science. 20: 37–47. doi:10.1016/j.euros.2020.06.006. ISSN 2666-1683. PMC 7497895. PMID 33000006.